LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Kidney Cancer Screen 42 Tissue Microarray - LS-SKICA42

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SKICA42
Product Name: Kidney Cancer Screen 42
Description: Mid-advanced stage kidney cancer and metastatic carcinoma with stage/grade
Format: FFPE
Category: Human Tumor
QA/QC: H&E reviewed
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Cases: 80
Cores: 80
Slides Per Set: 1

LS-SKICA42 Tissue Microarray Map

Slide Number 1
LABEL
 12345678910
AKidKidKidKidKidKidKidKidKidKid
BKidKidKidKidKidKidKidKidKidKid
CKidKidKidKidKidKidKidKidKidKid
DKidKidKidKidKidKidKidKidKidKid
EKidKidKidKidKidKidKidKidKidKid
FKidKidKidKidKidKidKidKidKidKid
GKidKidKidKidKidKidKidKidKidKid
HKidKidKidKidKidKidLymLymLymLym
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Kidney (Kid); Kidney, Fibrous tissue and blood vessel (Kid); Kidney, Renal pelvis (Kid); Lymph node (Lym);

LS-SKICA42 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTNM Tumor ClassificationTumor StageTumor Grade
1A1HumanM44 yKidney, Fibrous tissue and blood vessel (Kid)Clear cell carcinomaMalignantT2N0M0II
1A2HumanM39 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1-2
1A3HumanF49 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1-2
1A4HumanF64 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1A5HumanF71 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1A6HumanF54 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1A7HumanM74 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1A8HumanM60 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1A9HumanM67 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1A10HumanM73 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1B1HumanF38 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1B2HumanF40 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1B3HumanM39 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1B4HumanM64 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1B5HumanM48 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1B6HumanM42 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1-2
1B7HumanM40 yKidney, Fibrous tissue and blood vessel (Kid)Clear cell carcinomaMalignantT2N0M0II
1B8HumanF66 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1B9HumanM45 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1B10HumanM26 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C1HumanM35 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1C2HumanM51 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C3HumanM49 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C4HumanF57 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C5HumanM49 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C6HumanM74 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C7HumanM61 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C8HumanF33 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C9HumanM47 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II1
1C10HumanM51 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D1HumanM49 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D2HumanM52 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D3HumanF62 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D4HumanF53 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D5HumanM49 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D6HumanM56 yKidney (Kid)Clear cell carcinoma with necrosisMalignantT2N0M0II2
1D7HumanM68 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D8HumanM72 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D9HumanM59 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1D10HumanM55 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1E1HumanM58 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1E2HumanM38 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1E3HumanF69 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1E4HumanM46 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1E5HumanM41 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II2
1E6HumanF36 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II3
1E7HumanF42 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II3
1E8HumanM83 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II3
1E9HumanF57 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II3
1E10HumanM64 yKidney (Kid)Clear cell carcinomaMalignantT2N0M0II3
1F1HumanF52 yKidney (Kid)Transitional cell carcinomaMalignantT2N0M0II1
1F2HumanM53 yKidney (Kid)Transitional cell carcinomaMalignantT2N0M0II2
1F3HumanM53 yKidney (Kid)Transitional cell carcinomaMalignantT2N0M0II2
1F4HumanF75 yKidney (Kid)Transitional cell carcinomaMalignantT2N0M0II2
1F5HumanM47 yKidney (Kid)Transitional cell carcinomaMalignantT2N0M0II2
1F6HumanF65 yKidney (Kid)Transitional cell carcinomaMalignantT2N0M0II2-3
1F7HumanF40 yKidney (Kid)Transitional cell carcinomaMalignantT2N0M0II3
1F8HumanF40 yKidney (Kid)Carcinoma sarcomatodesMalignantT2N0M0II
1F9HumanF45 yKidney (Kid)Carcinoma sarcomatodesMalignantT2N0M0II
1F10HumanM54 yKidney (Kid)Carcinoma sarcomatodesMalignantT2N0M0II
1G1HumanM73 yKidney (Kid)Carcinoma sarcomatodesMalignantT2N0M0II
1G2HumanF33 yKidney (Kid)Papillary renal cell carcinomaMalignantT2N0M0II
1G3HumanF61 yKidney (Kid)Chromophobe renal cell carcinomaMalignantT2N0M0II
1G4HumanM70 yKidney (Kid)Clear cell carcinomaMalignantT3bN0M0III1
1G5HumanM62 yKidney, Renal pelvis (Kid)Clear cell carcinoma with chronic inflammationMalignantT3bN0M0III
1G6HumanM54 yKidney (Kid)Clear cell carcinomaMalignantT3bN0M0III2
1G7HumanM70 yKidney (Kid)Clear cell carcinomaMalignantT2N1M0III2
1G8HumanF58 yKidney (Kid)Clear cell carcinomaMalignantT3cN1M0III2
1G9HumanM55 yKidney (Kid)Transitional cell carcinomaMalignantT3bN0M0III2
1G10HumanM53 yKidney (Kid)Transitional cell carcinoma, PapillaryMalignantT3N0M0III1
1H1HumanM47 yKidney (Kid)Squamous cell carcinomaMalignantT3N0M0III2
1H2HumanF40 yKidney (Kid)Clear cell carcinomaMalignantT4N2M0IV2
1H3HumanF72 yKidney (Kid)Clear cell carcinomaMalignantT3aN0M1IV1
1H4HumanF50 yKidney (Kid)Clear cell carcinomaMalignantT4N1M0IV1
1H5HumanF30 yKidney (Kid)Clear cell carcinomaMalignantT3bN0M1IV1
1H6HumanM30 yKidney (Kid)Papillary renal cell carcinomaMalignantT1N0M1IV
1H7HumanM73 yLymph node (Lym)Metastasis from kidney squamous cell carcinomaMetastatic   
1H8HumanM35 yLymph node (Lym)Metastasis from kidney papillary renal cell carcinomaMetastatic   
1H9HumanF61 yLymph node (Lym)Metastasis from kidney transitional cell carcinomaMetastatic3
1H10HumanM43 yLymph node (Lym)Metastasis from kidney nephroblastomaMetastatic   
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved